DMHA (Octodrine) HCl – Solution, 3000mg (100mg/mL)

$29.99

DMHA (Octodrine) HCl Solution 3000mg (100mg/mL) is a laboratory-grade synthetic aliphatic amine compound (2-aminoisoheptane HCl) delivered in precise liquid solution form at 100mg/mL concentration, delivering 3000mg total in 30mL bottle. This investigational compound functions as a central nervous system (CNS) stimulant and sympathomimetic agent with dopamine and norepinephrine reuptake inhibitor activity, developed in the 1950s for use as an inhalant to treat bronchitis and laryngitis, demonstrating significant energy enhancement, focus improvement, concentration enhancement, and appetite suppression activity for modern scientific investigations. The solution is formulated in DMSO for optimal stability. Available for fast, compliant shipping to all 50 U.S. states and throughout European countries.

⚠️ Regulatory Notice: DMHA is not approved for dietary supplements, food, or medicine in the United States. The FDA considers DMHA an unsafe food additive and has issued 12 warning letters to companies. DMHA is on the DoD (Department of Defense) Prohibited Dietary Supplement Ingredients list.

  • Quality assurance with unique lot-coding and public third-party HPLC/MS lab reports for absolute transparency

  • Less than 10% variance in concentration, guaranteeing consistency

  • Formulated and packaged to prevent evaporation in storage

  • Includes graduated pipette for convenient measurement

  • Glass bottle with UV resistance to minimize degradation

  • Tamper-proof seal to ensure safety in transit

Category:
Description

DMHA (Octodrine) HCl – Solution, 3000mg (100mg/mL)

DMHA (Octodrine) HCl represents a premium, laboratory-grade investigational synthetic aliphatic amine compound delivered in precise liquid solution format at 100mg/mL concentration with 3000mg total quantity in 30mL bottle. This high-purity raw chemical material provides exceptional technical value to modern scientific investigations focused on CNS stimulant research, exercise performance studies, metabolic analysis, focus enhancement modeling, and dopamine/norepinephrine reuptake pathways. The liquid solution format at 100mg/mL ensures precise concentration accuracy and eliminates measurement variability for analytical testing and in vitro/in vivo modeling applications conducted by qualified investigators studying sympathetic nervous system activity and stimulant mechanisms. The solution is formulated in DMSO for optimal stability and contains less than 10% variance in concentration, guaranteeing consistency across batches.

⚠️ U.S. Regulatory Status: DMHA is classified as an unapproved drug by the FDA. Use in dietary supplements, food, or medicine is unlawful in the United States. The FDA has issued 12 warning letters to companies whose dietary supplements are labeled to contain DMHA.

Our global shipping infrastructure ensures seamless delivery to research facilities worldwide. Domestic orders within the United States ship directly from primary U.S. production facilities, ensuring rapid fulfillment across all 50 states. International orders, including all European countries, utilize our dedicated United Kingdom shipping hub to ensure seamless, efficient customs clearance across the UK and continental Europe, minimizing transit delays while maintaining chemical stability throughout shipment.

  • Unique lot-coding on every vessel with public third-party HPLC and mass spectrometry lab reports available for absolute transparency and quality verification

  • Less than 10% variance in concentration, guaranteeing consistency across batches

  • Formulation completely free of adulterants, excipients, flow agents, or stabilizers to guarantee unadulterated raw chemical purity for accurate research data

  • Includes graduated pipette for convenient and precise measurement

  • Glass bottle with UV resistance to minimize degradation during storage

  • Tamper-proof seal to ensure safety in transit

  • Packaging engineering utilizes formulation designed to prevent evaporation in storage


Technical Specifications & Chemical Profile

Chemical Property Specification Data
Product Name DMHA (Octodrine) HCl, 2-Aminoisoheptane HCl
Common Synonyms Octodrine, Dimethylhexylamine, DMHA, 1,5-Dimethylhexylamine, 2-Aminoisoheptane, 2-amino-5-methylheptane, 2-amino-6-methylheptane, 6-methyl-2-heptanamine, 2-Heptylamine, 6-methyl-, 2-Metil-6-amino-eptano, 2-isooctyl amine, 6-amino-2-methylheptane, 6-methyl-2-heptylamine, Amidrine, isoctaminum, Vaporpac, (1,5-Dimethylhexyl)ammonium chloride, 2-Amino-6-methylheptane hydrochloride, DMBA
CAS Number 5984-59-8
Molecular Formula C₈H₁₉N (base) / C₈H₁₉ClN (HCl salt)
Molar Mass 129.24 g/mol (base) / 165.7 g/mol (HCl salt)
IUPAC Name 6-methyl-2-heptanamine, monohydrochloride
Primary Target Mechanism Central nervous system (CNS) stimulant; sympathomimetic agent; α-adrenergic agonist; dopamine and norepinephrine reuptake inhibitor (increases uptake of dopamine and noradrenaline); similar effects to DMAA (boosting energy levels, focus, concentration, appetite suppression); alveolar decongestant; used in pre-workout supplements and fat burners; enhances energy; suppresses appetite; improves focus, memory, and attention; increases pain threshold; decreases perceived exertion; enhanced euphoria and alertness
Physical Form Liquid solution (100mg/mL ±10%, solved in DMSO)
Concentration 100mg/mL ±10% (3000mg in 30mL bottle)
Purity ≥98% (99%)
Solubility Dissolves well in DMSO at 100 mg/mL (77.41 mM)
Organoleptic Profile Clear solution
Regulatory Status US: Unapproved drug; use in dietary supplements, food, or medicine is unlawful. FDA considers DMHA an unsafe food additive; dietary supplements containing DMHA are adulterated and illegal for marketing. FDA issued 12 warning letters to companies. DoD Prohibited Dietary Supplement Ingredient. Animal studies suggest possible adverse cardiovascular effects. Potentially unsafe when taken by mouth — might cause heart attack and death

Research Applications & Storage Protocols

Sympathomimetic CNS Stimulant & α-Adrenergic Agonist Mechanisms

DMHA (also known as octodrine, dimethylhexylamine, and other names) is a central nervous system stimulant originally developed as an α-adrenergic agonist decongestant in the 1950s for use as an inhalant to treat bronchitis, laryngitis, and other conditions. It was never approved for oral use, but in recent years has resurfaced as an ingredient in sports and weight loss supplements. DMHA is a synthetic aliphatic amine compound demonstrating specific molecular interactions in experimental models with laboratory research indicating selective binding properties with various molecular targets. DMHA functions as a dopamine and norepinephrine reuptake inhibitor, increasing the uptake of dopamine and noradrenaline, contributing to its stimulant effects. DMHA offers similar effects to DMAA, boosting energy levels, focus, concentration, and appetite suppression, and is typically used in pre-workout supplements and fat burners. The distribution of enantiomers indicated that octodrine is likely synthetic, with detection of synthetic byproducts confirming artificial origin. It has been claimed to enhance focus, memory, and attention; increase pain threshold; and decrease rates of perceived exertion. DMHA provides enhanced euphoria and alertness. There hasn’t been enough research on DMHA to determine if it’s safe or effective, especially in humans. When taken by mouth, DMHA is possibly unsafe — might cause side effects similar to DMAA, including heart attack and death. The latest research from animal studies suggests DMHA might cause adverse cardiovascular (related to the heart or blood vessels) effects. The same concerns associated with other stimulants apply to DMHA. Research applications include CNS stimulant research, exercise performance studies, metabolic analysis, focus enhancement modeling, dopamine/norepinephrine reuptake pathway investigations, α-adrenergic agonist studies, sympathetic nervous system activity research, stimulant mechanism studies, and thermogenic activity research.

Handling & Storage Guidelines

  • Long-Term Storage: Store at -20°C (freezer). Keep container tightly sealed away from heat, light and moisture. Protect from moisture and light. Avoid repeated freeze-thaw cycles. Do NOT freeze once reconstituted (though this solution is already in DMSO). For solvent storage, do not recommend long-term storage — use soon. Shelf life up to 2 years when stored properly.

  • Solubility: Soluble in DMSO at 100 mg/mL (77.41 mM). Includes graduated pipette for convenient measurement.

  • Concentration: 100mg/mL ±10% (3000mg total in 30mL/1 fl oz bottle).

  • Appearance: Clear solution in glass vial with UV resistance.

  • Safety Warning: DMHA is possibly unsafe when taken orally — may cause heart attack and death. Causes skin irritation, serious eye irritation, and may cause respiratory irritation. Not for food, drug, human, animal, household, diagnostic or therapeutic use. Intended for forensic or research purposes only.

Global Logistics & Order Fulfillment

We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.

Laboratory Use Only Disclaimer

This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.

Additional information
pa_feature

Discountinued

pa_form

Liquids

pa_types

Peptides

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “DMHA (Octodrine) HCl – Solution, 3000mg (100mg/mL)”